Publication
Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity
Related publications (32)
Freddy Radtke, Nadine Fournier, Amber Dawn Bowler, Etienne Meylan, Anita Bodac, Justine Pascual, Vincent Roh
Henning Paul-Julius Stahlberg, Dongchun Ni
Filipe Amândio Brandão Sanches Vong Martins